Quality of Reproductive Care in Women with Von Willebrand Disease
患有冯维勒布兰德病的女性的生殖护理质量
基本信息
- 批准号:8956508
- 负责人:
- 金额:$ 10.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-01 至 2017-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdolescentAdvocacyAgeAmericanAreaCaringCharacteristicsClinicalDataDatabasesDiagnosisDiagnosticDiseaseEarly DiagnosisEvaluationFrequenciesFundingFutureGoalsGuidelinesHealthHealth Services AccessibilityHealthcareHealthy People 2020Hemophilia AHemorrhageHemostatic functionHysterectomyInstitutionInsuranceInterventionIntervention StudiesIron deficiency anemiaLeadMenstruationMonitorMorbidity - disease rateNational Heart, Lung, and Blood InstituteOperative Surgical ProceduresPatientsPlasmaPopulation HeterogeneityPostpartum HemorrhagePregnancyPregnant WomenPrevalenceQuality of CareQuality of lifeRecommendationReproductive HealthResearchRiskSpecialistThird Pregnancy TrimesterThrombosisTimeUnited StatesWomanWorkaccurate diagnosisagedbasehigh riskimprovedmedical specialtiespatient registrypopulation basedpreventpublic health relevancereproductivereproductive morbidityscreeningtreatment centervon Willebrand Disease
项目摘要
DESCRIPTION (provided by applicant): Approximately 2 million women (-1% of all women) in the United States may have an undiagnosed bleeding disorder, yet many of these disorders remain undetected for years or are never diagnosed. Women with bleeding disorders are at increased risk for heavy menstrual bleeding, iron deficiency anemia, antepartum bleeding, postpartum hemorrhage, and may undergo unnecessary hysterectomy and other uterine surgeries that can lead to additional complications. A common bleeding disorder in women is von Willebrand disease (VWD), defined as a quantitative or qualitative deficiency of von Willebrand factor. To decrease the frequency and morbidity of complications from undiagnosed VWD, expert guidelines recommend screening for VWD in adolescents with heavy menses and prior to any hysterectomy for heavy menses. For pregnant women with diagnosed VWD, third trimester monitoring of VWF is recommended to best plan for a safe labor and delivery and reduce the risk of postpartum hemorrhage. Although VWD is a common disease, with an estimated prevalence of 1.6 million American women, past research in this area has been primarily limited to single institution settings or patient registries derived from hemophilia treatment centers. Women with milder disease or limited access to treatment centers are therefore underrepresented. Our long-term goal is to perform research that aids in decreasing the frequency and morbidity of reproductive bleeding in women with underlying bleeding disorders. Utilizing administrative claims data to study bleeding complications in women with VWD will provide our team unique access to a large and diverse population of women diagnosed with VWD, including those with mild disease. In the proposed study we will utilize the ClinformaticsDataMart, a longitudinal health care database representing >45 million covered lives (including >7,000 reproductive-aged women with VWD), to investigate the quality of reproductive health care in women with VWD during the time period of 2000-2013. The specific aims of our proposal are to: 1) investigate the impact of distance to hemophilia treatment centers and other patient and facility characteristics on the frequency of VWD screening in adolescents with heavy menses and women undergoing hysterectomy for excessive bleeding, and 2) identify the population-based frequency and timing of postpartum hemorrhage, and compare the frequency of postpartum hemorrhage in women with VWD or do and do not undergo third trimester VWF monitoring. Identifying gaps in reproductive care in women with diagnosed VWD and those at risk for VWD will allow for targeted educational and advocacy efforts, and improved implementation of interventions to mitigate the consequences of VWD in reproductive-age women and eliminate barriers to high quality care. Our research seeks to identify barriers to implementation of the NHLBI's and other expert guidelines regarding the evaluation and management of VWD, and supports the Healthy People 2020 goal to increase the proportion of women with VWD who receive a timely and accurate diagnosis.
描述(由申请人提供):美国约有200万女性(占所有女性的1%)可能患有未诊断的出血性疾病,但其中许多疾病多年未被发现或从未被诊断出来。有出血性疾病的妇女月经大出血、缺铁性贫血、产前出血、产后出血的风险增加,并且可能进行不必要的子宫切除术和其他子宫手术,这些手术可能导致额外的并发症。女性常见的出血性疾病是血管性血友病(VWD),定义为血管性血友病因子的定量或定性缺乏。为了减少未确诊的VWD并发症的发生率和发病率,专家指南建议在月经量大的青少年中进行VWD筛查,并在因月经量大而进行子宫切除术之前进行筛查。对于诊断为VWD的孕妇,建议在妊娠晚期监测VWF,以最好地计划安全分娩和分娩,并降低产后出血的风险。尽管VWD是一种常见疾病,估计有160万美国妇女患病,但过去在这一领域的研究主要限于单一机构设置或血友病治疗中心的患者登记。因此,病情较轻或进入治疗中心的机会有限的妇女人数不足。我们的长期目标是进行研究,帮助降低潜在出血性疾病女性生殖道出血的频率和发病率。利用行政索赔数据来研究VWD女性的出血并发症,将为我们的团队提供独特的途径,以获得大量不同的VWD女性诊断人群,包括那些轻度疾病。在拟议的研究中,我们将利用ClinformaticsDataMart,一个纵向医疗保健数据库,代表超过4500万人的生命(包括超过7,000名育龄女性VWD),调查2000-2013年期间VWD女性的生殖保健质量。我们建议的具体目标是:1)调查与血友病治疗中心的距离以及其他患者和机构特征对月经量大的青少年和因出血过多而接受子宫切除术的女性进行VWD筛查频率的影响,以及2)确定基于人群的产后出血频率和时间,比较VWD妇女与未进行VWF监测的妇女产后出血的频率。查明诊断为VWD的妇女和有VWD风险的妇女在生殖保健方面的差距,将有助于开展有针对性的教育和宣传工作,并改善干预措施的实施,以减轻VWD对育龄妇女的影响,消除获得高质量保健的障碍。我们的研究旨在确定实施NHLBI和其他专家指南关于VWD评估和管理的障碍,并支持2020年健康人的目标,以提高VWD女性的比例,及时准确地诊断。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SARAH H. OBRIEN其他文献
SARAH H. OBRIEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SARAH H. OBRIEN', 18)}}的其他基金
Developing Primary Care Algorithms for Early Identification of Young Women with von Willebrand Disease
开发初级保健算法以早期识别患有冯维勒布兰德病的年轻女性
- 批准号:
10673876 - 财政年份:2022
- 资助金额:
$ 10.21万 - 项目类别:
Development of Multi-Platform Mobile App Technology for Real-Time Measurement of Menstrual Cycle Characteristics in Adolescents
开发实时测量青少年月经周期特征的多平台移动应用程序技术
- 批准号:
9978426 - 财政年份:2020
- 资助金额:
$ 10.21万 - 项目类别:
Reproductive Care in Women with Sickle Cell Disease - Use of Secondary Data to Investigate Risk of Contraception-Related Thrombosis and the Impact of Hydroxyurea on Pregnancy Outcomes
镰状细胞病女性的生殖护理 - 利用二手数据调查避孕相关血栓形成的风险以及羟基脲对妊娠结局的影响
- 批准号:
10094247 - 财政年份:2020
- 资助金额:
$ 10.21万 - 项目类别:
Quality of Reproductive Care in Women with Von Willebrand Disease
患有冯维勒布兰德病的女性的生殖护理质量
- 批准号:
9134181 - 财政年份:2015
- 资助金额:
$ 10.21万 - 项目类别:
DVT Prevention in Pediatric and Adolescent Trauma Patients: Safety and Costs
儿童和青少年创伤患者的 DVT 预防:安全性和成本
- 批准号:
7386804 - 财政年份:2007
- 资助金额:
$ 10.21万 - 项目类别:
相似海外基金
Transfer Advocacy Groups: Transforming Culture to Support Community College Transfer Students of Color in Undergraduate Physics
转学倡导团体:转变文化以支持社区学院本科物理有色人种转学生
- 批准号:
2224295 - 财政年份:2023
- 资助金额:
$ 10.21万 - 项目类别:
Continuing Grant
Engaging adolescents for sexual and reproductive health and rights and family planning advocacy in Pakistan.
让巴基斯坦青少年参与性健康和生殖健康及权利以及计划生育宣传。
- 批准号:
490127 - 财政年份:2023
- 资助金额:
$ 10.21万 - 项目类别:
Operating Grants
Developing a network for mutual learning on the potential of creative arts for mental health advocacy and activism in Ghana and Indonesia
建立一个网络,以相互学习创意艺术在加纳和印度尼西亚促进心理健康倡导和行动的潜力
- 批准号:
AH/X009637/1 - 财政年份:2023
- 资助金额:
$ 10.21万 - 项目类别:
Research Grant
Protection without Advocacy: Japan's Failure to Support Persons with Mental Disabilities in the community
没有倡导的保护:日本未能支持社区中的精神残疾人
- 批准号:
23K01937 - 财政年份:2023
- 资助金额:
$ 10.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Developing a cultural adaptation framework for youth mental health education and advocacy initiatives at Jack.org
Jack.org 为青少年心理健康教育和宣传活动制定文化适应框架
- 批准号:
484618 - 财政年份:2023
- 资助金额:
$ 10.21万 - 项目类别:
Fellowship Programs
8th International RASopathies Symposium: Expanding Research and Care Practice through Global Collaboration and Advocacy
第八届国际 RASopathies 研讨会:通过全球合作和宣传扩大研究和护理实践
- 批准号:
10683644 - 财政年份:2023
- 资助金额:
$ 10.21万 - 项目类别:
Lupus and health information: Evidence-informed advocacy in action
狼疮和健康信息:循证宣传在行动
- 批准号:
485670 - 财政年份:2023
- 资助金额:
$ 10.21万 - 项目类别:
Miscellaneous Programs
Initiating Meaningful Partnerships for Advocacy and Collaborative Training: The IMPACT initiative
发起有意义的倡导和协作培训伙伴关系:IMPACT 倡议
- 批准号:
487847 - 财政年份:2023
- 资助金额:
$ 10.21万 - 项目类别:
Miscellaneous Programs
Creating advocacy and tech to make secondhand first choice.
创造宣传和技术,让二手货成为首选。
- 批准号:
10064859 - 财政年份:2023
- 资助金额:
$ 10.21万 - 项目类别:
Collaborative R&D
Advocacy Strategies supporting Social Determinants of Health: Paving the Path to Community Reintegration and Recovery
支持健康问题社会决定因素的倡导策略:为社区重新融入和恢复铺平道路
- 批准号:
480718 - 财政年份:2023
- 资助金额:
$ 10.21万 - 项目类别:
Miscellaneous Programs